Cargando…
Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach
Tigecycline (Tgc) is considered a last-resort antibiotic for the treatment of multi-drug resistant bacteria. To study Tgc resistance development in the important nosocomial pathogen Acinetobacter baumannii, we adopted six clinical isolates from three patients undergoing antibiotic treatment, and bac...
Autores principales: | Liu, Lin, Cui, Yujun, Zheng, Beiwen, Jiang, Saiping, Yu, Wei, Shen, Ping, Ji, Jinru, Li, Lanjuan, Qin, Nan, Xiao, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886253/ https://www.ncbi.nlm.nih.gov/pubmed/27240484 http://dx.doi.org/10.1038/srep26930 |
Ejemplares similares
-
Comparative Genomic Analysis of 19 Clinical Isolates of Tigecycline-Resistant Acinetobacter baumannii
por: Liu, Lin, et al.
Publicado: (2020) -
The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020) -
Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023) -
Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
por: Jo, Jeongwoo, et al.
Publicado: (2021) -
Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients
por: Zhang, Jiangang, et al.
Publicado: (2022)